SITC/iSBTc cancer immunotherapy biomarkers resource document: online resources and useful tools - a compass in the land of biomarker discovery
Academic Article
Publication Date:
2011
Short description:
SITC/iSBTc cancer immunotherapy biomarkers resource document: online resources and useful tools - a compass in the land of biomarker discovery / Bedognetti, Davide; Wang, Ena; Disis, Mary L.; Britten, Cedrik M.; Tomei, Sara; Fox, Bernard A.; Marincola, Francesco M.; Butterfield, Lisa H.; Balwit, James M.; Delogu, Lucia Gemma; Gajewski, Thomas F.. - 9:155(2011), pp. 1-20. [10.1186/1479-5876-9-155]
abstract:
Recent positive clinical results in cancer immunotherapy point to the potential of immune-based strategies to
provide effective treatment of a variety of cancers. In some patients, the responses to cancer immunotherapy are
durable, dramatically extending survival. Extensive research efforts are being made to identify and validate
biomarkers that can help identify subsets of cancer patients that will benefit most from these novel
immunotherapies. In addition to the clear advantage of such predictive biomarkers, immune biomarkers are
playing an important role in the development, clinical evaluation and monitoring of cancer immunotherapies. This
Cancer Immunotherapy Resource Document, prepared by the Society for Immunotherapy of Cancer (SITC, formerly
the International Society for Biological Therapy of Cancer, iSBTc), provides key references and online resources
relevant to the discovery, evaluation and clinical application of immune biomarkers. These key resources were
identified by experts in the field who are actively pursuing research in biomarker identification and validation. This
organized collection of the most useful references, online resources and tools serves as a compass to guide
discovery of biomarkers essential to advancing novel cancer immunotherapies.
provide effective treatment of a variety of cancers. In some patients, the responses to cancer immunotherapy are
durable, dramatically extending survival. Extensive research efforts are being made to identify and validate
biomarkers that can help identify subsets of cancer patients that will benefit most from these novel
immunotherapies. In addition to the clear advantage of such predictive biomarkers, immune biomarkers are
playing an important role in the development, clinical evaluation and monitoring of cancer immunotherapies. This
Cancer Immunotherapy Resource Document, prepared by the Society for Immunotherapy of Cancer (SITC, formerly
the International Society for Biological Therapy of Cancer, iSBTc), provides key references and online resources
relevant to the discovery, evaluation and clinical application of immune biomarkers. These key resources were
identified by experts in the field who are actively pursuing research in biomarker identification and validation. This
organized collection of the most useful references, online resources and tools serves as a compass to guide
discovery of biomarkers essential to advancing novel cancer immunotherapies.
Iris type:
1.1 Articolo in rivista
Keywords:
Society for Immunotherapy of Cancer (SITC); cancer immunotherapy; clinical results
List of contributors: